OPKO Diagnostics

OPKO Diagnostics, located at 4 Constitution Way in Woburn, Massachusetts, is a health institution that is part of OPKO Health, a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases worldwide. With a dedicated management team and partnerships with leading pharmaceutical companies, OPKO Health is committed to advancing proven technologies to improve patients' lives.

One of their FDA-approved therapies is NGENLA™, a next-generation human growth hormone therapy for pediatric growth hormone deficiency patients. This innovative medicine, approved in over 40 markets worldwide through a partnership with Pfizer, has the potential to transform the treatment landscape for growth hormone deficiencies.

OPKO Health is also focused on developing multispecific therapies to treat various serious conditions such as cancers and infectious diseases. Their research and development team, comprised of experts from prestigious organizations, has attracted partnerships with companies like Merck, N.I.H., and BARDA.

As one of the largest full-service clinical reference laboratories in the U.S., serving approximately 11 million patients annually, BioReference Laboratories, part of OPKO Health, continues to deliver innovations for patients and physicians, particularly in specialty areas.

With a proven track record of partnering with global organizations, OPKO Health ensures the transformative potential of their research reaches a large number of patients worldwide. For more information, visit OPKO Health at their headquarters in Miami, Florida.